1. Home
  2. LSTA vs NTWK Comparison

LSTA vs NTWK Comparison

Compare LSTA & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • NTWK
  • Stock Information
  • Founded
  • LSTA 1980
  • NTWK 1997
  • Country
  • LSTA United States
  • NTWK United States
  • Employees
  • LSTA N/A
  • NTWK N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • LSTA Health Care
  • NTWK Technology
  • Exchange
  • LSTA Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • LSTA 31.2M
  • NTWK 31.1M
  • IPO Year
  • LSTA N/A
  • NTWK 1998
  • Fundamental
  • Price
  • LSTA $2.61
  • NTWK $2.65
  • Analyst Decision
  • LSTA Strong Buy
  • NTWK
  • Analyst Count
  • LSTA 1
  • NTWK 0
  • Target Price
  • LSTA $15.00
  • NTWK N/A
  • AVG Volume (30 Days)
  • LSTA 66.3K
  • NTWK 14.5K
  • Earning Date
  • LSTA 02-27-2025
  • NTWK 02-13-2025
  • Dividend Yield
  • LSTA N/A
  • NTWK N/A
  • EPS Growth
  • LSTA N/A
  • NTWK N/A
  • EPS
  • LSTA N/A
  • NTWK 0.06
  • Revenue
  • LSTA N/A
  • NTWK $61,749,408.00
  • Revenue This Year
  • LSTA N/A
  • NTWK N/A
  • Revenue Next Year
  • LSTA N/A
  • NTWK N/A
  • P/E Ratio
  • LSTA N/A
  • NTWK $42.16
  • Revenue Growth
  • LSTA N/A
  • NTWK 14.50
  • 52 Week Low
  • LSTA $2.19
  • NTWK $2.09
  • 52 Week High
  • LSTA $4.20
  • NTWK $3.34
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 42.17
  • NTWK 53.53
  • Support Level
  • LSTA $2.45
  • NTWK $2.52
  • Resistance Level
  • LSTA $2.74
  • NTWK $2.78
  • Average True Range (ATR)
  • LSTA 0.32
  • NTWK 0.12
  • MACD
  • LSTA -0.05
  • NTWK 0.01
  • Stochastic Oscillator
  • LSTA 16.48
  • NTWK 71.15

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.

Share on Social Networks: